JZP-385 is a small molecule that acts as a T-type calcium channel antagonist. This therapy aims to address motor impairment by inhibiting calcium channels that contribute to motor control and coordination, potentially reducing symptoms related to motor dysfunction in Parkinson's disease.
Discover our Products
Science-based and high-quality devices
